DK0420264T3 - Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on - Google Patents
Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-onInfo
- Publication number
- DK0420264T3 DK0420264T3 DK90118673.4T DK90118673T DK0420264T3 DK 0420264 T3 DK0420264 T3 DK 0420264T3 DK 90118673 T DK90118673 T DK 90118673T DK 0420264 T3 DK0420264 T3 DK 0420264T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzothiazepine
- acetoxy
- dimethylaminoethyl
- methoxyphenyl
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/414,381 US5002773A (en) | 1989-09-29 | 1989-09-29 | Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0420264T3 true DK0420264T3 (da) | 1991-06-19 |
Family
ID=23641207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90118673.4T DK0420264T3 (da) | 1989-09-29 | 1990-09-28 | Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on |
Country Status (6)
Country | Link |
---|---|
US (1) | US5002773A (da) |
EP (1) | EP0420264A3 (da) |
JP (1) | JPH03157332A (da) |
AU (1) | AU628660B2 (da) |
CA (1) | CA2026293A1 (da) |
DK (1) | DK0420264T3 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963545A (en) * | 1988-05-24 | 1990-10-16 | Marion Laboratories, Inc. | Benzothiazepine anti-seizure method |
US5383848A (en) * | 1990-04-12 | 1995-01-24 | Gensia, Inc. | Iontophoretic administration of drugs |
IT1243745B (it) * | 1990-10-17 | 1994-06-21 | Vectorpharma Int | Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione. |
US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
EP1532115A4 (en) * | 2002-05-22 | 2006-01-11 | Smithkline Beecham Corp | INHIBITORS OF PROTEASE |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3531545A1 (de) * | 1985-09-04 | 1987-03-05 | Goedecke Ag | Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung |
US4879289A (en) * | 1988-05-24 | 1989-11-07 | Marion Laboratories, Inc. | Method of ameliorating epileptic seizures |
-
1989
- 1989-09-29 US US07/414,381 patent/US5002773A/en not_active Expired - Fee Related
-
1990
- 1990-09-26 CA CA002026293A patent/CA2026293A1/en not_active Abandoned
- 1990-09-26 AU AU63644/90A patent/AU628660B2/en not_active Ceased
- 1990-09-28 JP JP2257562A patent/JPH03157332A/ja active Pending
- 1990-09-28 DK DK90118673.4T patent/DK0420264T3/da active
- 1990-09-28 EP EP19900118673 patent/EP0420264A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU6364490A (en) | 1991-04-11 |
US5002773A (en) | 1991-03-26 |
AU628660B2 (en) | 1992-09-17 |
JPH03157332A (ja) | 1991-07-05 |
CA2026293A1 (en) | 1991-03-30 |
EP0420264A2 (en) | 1991-04-03 |
EP0420264A3 (en) | 1991-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK19388D0 (da) | Fremmstilling af aromatiske, heterocykliske polymerer | |
DK177690D0 (da) | Behandling af fedme | |
DK112387A (da) | Rensning af alfa-1-antiprotease | |
DK662687A (da) | Anvendelse af tricycliske carbazoloner | |
DK0420264T3 (da) | Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on | |
DK1066292T3 (da) | Metallocorrinoider som biologisk kompatible bærere af farmakologiske midler | |
DE69111915D1 (de) | Pyrido(2,3-f)(1,4)thiazepine und Pyrido(3,2-b)(1,5)benzothiazepine. | |
DK0875579T3 (da) | Fremstilling af L(+)-laktat | |
DK199587A (da) | Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner | |
DK0941081T3 (da) | Ny anvendelse af creatin | |
DK199487D0 (da) | Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner | |
IT9022340A0 (it) | Processo per la preparazione del (+)-cis-3-(acetossi)-5-(2-(dimetilammino)etil)-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato. | |
DK80990A (da) | Sulfonylderivater af thien-triazol-diazepin | |
DK120389A (da) | Anvendelse af progestin | |
ES2023774A6 (es) | Procedimiento para la preparacion del intermedio de diltiazem. | |
DK104389A (da) | Anvendelse af imidazolderivater | |
ATE227733T1 (de) | Herstellung von avermectin-verbindungen | |
DK681088D0 (da) | Ae3-hydroxy-2(4-methoxyphenyl)-5-(2-methylaminoethyl)-2,3-dihydro-1,5-5h-benzothiazepin-4-on-derivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne derivaterae | |
DK104489A (da) | Anvendelse af triazolderivater | |
SE9002410D0 (sv) | Foerfarande foer rening av mellanprodukter | |
IT8521855A0 (it) | Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato | |
IT1237204B (it) | Procedimento per la preparazione di 2-aril-3-idrossi-cis-2,3-diidro- 1,5-benzotiazepin-4(5h)-oni e derivati | |
DK0882722T3 (da) | Fremstilling af alpha-tocopherol | |
IT8422701A0 (it) | Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato | |
DK732088A (da) | Fremgangsmaade til fremstilling af 1,5-benzothiazepinderivater |